Compare GRC & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRC | NEOG |
|---|---|---|
| Founded | 1933 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 1994 | 1995 |
| Metric | GRC | NEOG |
|---|---|---|
| Price | $74.89 | $8.97 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.67 |
| AVG Volume (30 Days) | 86.5K | ★ 2.3M |
| Earning Date | 04-23-2026 | 04-09-2026 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | ★ 32.03 | N/A |
| EPS | ★ 0.68 | 0.02 |
| Revenue | $682,389,000.00 | ★ $894,661,000.00 |
| Revenue This Year | $6.62 | N/A |
| Revenue Next Year | $4.66 | N/A |
| P/E Ratio | ★ $110.06 | $467.75 |
| Revenue Growth | ★ 3.44 | N/A |
| 52 Week Low | $34.96 | $4.53 |
| 52 Week High | $79.54 | $11.43 |
| Indicator | GRC | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 55.18 | 49.47 |
| Support Level | $43.10 | $8.98 |
| Resistance Level | $79.02 | $10.12 |
| Average True Range (ATR) | 2.25 | 0.39 |
| MACD | -0.28 | 0.08 |
| Stochastic Oscillator | 62.97 | 62.74 |
Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of its revenue from the United States.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.